These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19835658)

  • 1. Prenatal exposure to phencyclidine produces abnormal behaviour and NMDA receptor expression in postpubertal mice.
    Lu L; Mamiya T; Lu P; Toriumi K; Mouri A; Hiramatsu M; Kim HC; Zou LB; Nagai T; Nabeshima T
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):877-89. PubMed ID: 19835658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal exposure to PCP produces behavioral deficits accompanied by the overexpression of GLAST in the prefrontal cortex of postpubertal mice.
    Lu L; Mamiya T; Lu P; Toriumi K; Mouri A; Hiramatsu M; Zou LB; Nabeshima T
    Behav Brain Res; 2011 Jun; 220(1):132-9. PubMed ID: 21277907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subchronic treatment with phencyclidine in adolescence leads to impaired exploratory behavior in adult rats without altering social interaction or N-methyl-D-aspartate receptor binding levels.
    Metaxas A; Willems R; Kooijman EJ; Renjaän VA; Klein PJ; Windhorst AD; Donck LV; Leysen JE; Berckel BN
    J Neurosci Res; 2014 Nov; 92(11):1599-607. PubMed ID: 24953757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronic prenatal MK-801 treatment on object recognition, cognitive flexibility, and drug-induced locomotor activity in juvenile and adult rat offspring.
    Gallant S; Welch L; Martone P; Shalev U
    Behav Brain Res; 2017 Jun; 328():62-69. PubMed ID: 28390877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment.
    Mouri A; Noda Y; Enomoto T; Nabeshima T
    Neurochem Int; 2007; 51(2-4):173-84. PubMed ID: 17669558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive role of regular low-intensity exercise during adolescence in schizophrenia model mice with abnormal behaviors.
    Koizumi H; Hiraga T; Oharomari LK; Hata T; Shima T; Yook JS; Okamoto M; Mouri A; Nabeshima T; Soya H
    Biochem Biophys Res Commun; 2021 Jan; 534():610-616. PubMed ID: 33228965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated low dose of phencyclidine administration impairs spatial learning in mice: blockade by clozapine but not by haloperidol.
    Beraki S; Kuzmin A; Tai F; Ogren SO
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):486-97. PubMed ID: 18242064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential role of N-methyl-D-aspartate receptor subunits 2A and 2B in mediating phencyclidine-induced perinatal neuronal apoptosis and behavioral deficits.
    Anastasio NC; Xia Y; O'Connor ZR; Johnson KM
    Neuroscience; 2009 Nov; 163(4):1181-91. PubMed ID: 19654040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
    Nabeshima T; Mouri A; Murai R; Noda Y
    Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat.
    Klamer D; Zhang J; Engel JA; Svensson L
    Behav Brain Res; 2005 Apr; 159(1):95-103. PubMed ID: 15795002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit.
    Chaperon F; Müller W; Auberson YP; Tricklebank MD; Neijt HC
    Behav Pharmacol; 2003 Sep; 14(5-6):477-87. PubMed ID: 14501261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Δ9-tetrahydrocannabinol (Δ9-THC) administration after neonatal exposure to phencyclidine potentiates schizophrenia-related behavioral phenotypes in mice.
    Rodríguez G; Neugebauer NM; Yao KL; Meltzer HY; Csernansky JG; Dong H
    Pharmacol Biochem Behav; 2017 Aug; 159():6-11. PubMed ID: 28648819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal phencyclidine treatment induces behavioral deficits through impairment of GABAergic interneurons in the prefrontal cortex.
    Toriumi K; Oki M; Muto E; Tanaka J; Mouri A; Mamiya T; Kim HC; Nabeshima T
    Psychopharmacology (Berl); 2016 Jun; 233(12):2373-81. PubMed ID: 27095448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia.
    Wang C; McInnis J; Ross-Sanchez M; Shinnick-Gallagher P; Wiley JL; Johnson KM
    Neuroscience; 2001; 107(4):535-50. PubMed ID: 11720778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sustained phencyclidine exposure on sensorimotor gating of startle in rats.
    Martinez ZA; Ellison GD; Geyer MA; Swerdlow NR
    Neuropsychopharmacology; 1999 Jul; 21(1):28-39. PubMed ID: 10379517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of p75 neurotrophin receptor and Myelin transcription factor 1 in the hippocampus of perinatal phencyclidine treated rats.
    Andrews JL; Newell KA; Matosin N; Huang XF; Fernandez-Enright F
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Dec; 63():91-7. PubMed ID: 26071990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The involvement of distraction in memory deficits induced by NMDAR antagonism: relevance to cognitive deficits in schizophrenia.
    Grayson B; Adamson L; Harte M; Leger M; Marsh S; Piercy C; Neill JC
    Behav Brain Res; 2014 Jun; 266():188-92. PubMed ID: 24632009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short and long term changes in NMDA receptor binding in mouse brain following chronic phencyclidine treatment.
    Newell KA; Zavitsanou K; Huang XF
    J Neural Transm (Vienna); 2007; 114(8):995-1001. PubMed ID: 17401537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression of synapsin II in a chronic phencyclidine preclinical rat model of schizophrenia.
    Thomson S; Dyck B; Daya R; Ho J; Bernardo A; Tian Y; Mishra RK
    Synapse; 2019 May; 73(5):e22084. PubMed ID: 30582667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sodium benzoate on pre-pulse inhibition deficits and hyperlocomotion in mice after administration of phencyclidine.
    Matsuura A; Fujita Y; Iyo M; Hashimoto K
    Acta Neuropsychiatr; 2015 Jun; 27(3):159-67. PubMed ID: 25648314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.